2610
A. Sharma et al. / Tetrahedron 64 (2008) 2605e2610
2.3.10. 1-(4-Methoxybenzyl)-5-chloro-3-(piperidin-1-
References and notes
yl)pyrazin-2(1H)-one (3a)
1
Yield 98%, orange crystalline, mp 125e126 ꢀC. H NMR
(300 MHz, CDCl3): d 7.24 (d, J¼9.1 Hz, 2H), 6.86 (d,
J¼10.1 Hz, 2H), 6.60 (s, 1H), 4.89 (s, 2H), 3.83 (s, 4H,
eNe(CH2)2), 3.77 (s, 3H, eOMe), 1.64 (s, 6H, eCe(CH2)3).
13C NMR (75 MHz, CDCl3): d 159.6, 151.3, 151.2, 129.8,
127.3, 125.6, 114.3, 114.2, 55.3, 51.6, 47.9, 26.1, 24.7.
HRMS (EI): C17H20ClN3O2 calcd 333.1244, found 333.1241.
1. Dictionary of Natural products; Buckingham, J., Ed.; Chapman and Hall:
London, 1993; (b) Dictionary of Organic Compounds; Buckingham, J.,
MacDonald, F., Eds.; Chapman and Hall: London, 1996.
2. (a) For detailed description, see review: Baloglu, E.; Kingston, D. G. I.
J. Nat. Prod. 1999, 62, 1448e1472 and references cited therein; (b) Ste-
fanowicz, P.; Prasain, J. K.; Yeboah, K. F.; Konishi, Y. Anal. Chem. 2001,
73, 3583e3589.
3. (a) Charest, M. G.; Lerner, C. D.; Brubakar, J. D.; Siegel, D. R.; Myers,
A. G. Science 2005, 308, 395e398; (b) Charest, M. G.; Siegel, D. R.;
Myers, A. G. J. Am. Chem. Soc. 2005, 127, 8292e8293.
2.3.11. 1-(4-Methoxybenzyl)-5-chloro-3-morpholino-
pyrazin-2(1H)-one (3b)
4. Doss, R. P.; Carney, J. R.; Shanks, C. H., Jr.; Williamson, R. T.; Chamber-
lain, J. D. J. Nat. Prod. 1997, 60, 1130e1133.
1
Yield 91%, brown crystalline, mp 168e170 ꢀC. H NMR
5. (a) Schultz, E. M.; Robb, C. M.; Sprague, J. M. J. Am. Chem. Soc. 1947,
69, 2454e2459; (b) Takahashi, T.; Kenematsu, K. Chem. Pharm. Bull.
1958, 6, 98; (c) Elias, R. S.; Shephard, M. C.; Snell, B. K.; Stubbs, J.
Nature 1968, 219, 1160; (d) Hutzenlaub, W.; Tolman, R. L.; Robins,
R. K. J. Med. Chem. 1972, 15, 879e883.
(300 MHz, CDCl3): d 7.25 (d, J¼9.4 Hz, 2H), 6.88 (d,
J¼9.4 Hz, 2H), 6.67 (s, 1H), 4.89 (s, 2H), 3.93e3.90 (m,
4H, eNe(CH2)2), 3.79 (s, 3H, eOMe), 3.70 (d, 4H, eOe
(CH2)2). 13C NMR (75 MHz, CDCl3): d 159.8, 151.2, 150.8,
130.0, 127.1, 125.5, 115.4, 114.4, 66.8, 55.4, 51.7, 47.2.
HRMS (EI): C17H20ClN3O2 calcd 335.1037, found 335.1046.
´
6. (a) Neant, I.; Guerrier, P. Exp. Cell Res. 1988, 176, 68e79; (b) Rime, H.;
Neant, I.; Guerrier, P.; Ozon, R. Dev. Biol. 1989, 133, 169e179; (c) Beux,
G. L.; Richard, F. J.; Sirard, M.-A. Theriogenology 2003, 60, 1049e1058.
7. (a) Lurthy, N. G.; Bergstrom, F. W.; Mosher, H. S. J. Am. Chem. Soc.
1949, 71, 1109e1110; (b) Coppinger, G. M. J. Am. Chem. Soc. 1954,
76, 1372e1373; (c) Heindel, N.; Kennewell, P. J. Chem. Soc., Chem.
Commun. 1969, 38; (d) Watanabe, T.; Tanaka, Y.; Sekiya, K.; Akita, Y.;
Ohta, A. Synthesis 1980, 39; (e) Cho, Y. H.; Park, J. C. Tetrahedron
Lett. 1997, 38, 8331e8334; (f) Agarwal, A.; Chauhan, P. M. S. Synth.
Commun. 2004, 34, 2925e2930.
2.3.12. 1-(4-Methoxybenzyl)-3-(N-benzyl-N-methylamino)-
5-chloropyrazin-2(1H)-one (3c)
Yield 72%, yellow oil. 1H NMR (300 MHz, CDCl3):
d 7.29e7.23 (m, 7H), 6.87 (d, J¼9.1 Hz, 2H), 6.59 (s, 1H),
5.12 (s, 2H), 4.91 (s, 2H), 3.79 (s, 3H), 3.14 (s, 3H). 13C
NMR (75 MHz, CDCl3): d 159.7, 151.3, 151.1, 142.7, 138.2,
129.8, 128.0, 127.7, 127.4, 126.8, 125.9, 114.1, 54.9, 51.6,
51.2, 38.3. HRMS (EI): C20H20ClN3O2 calcd 369.1244, found
369.1248.
8. (a) Radi, M.; Petricci, E.; Maga, G.; Corelli, F.; Botta, M. J. Comb. Chem.
2005, 7, 117e122; (b) Rombouts, F. J. R.; Fridkin, G.; Lubell, W. D.
J. Comb. Chem. 2005, 7, 589e598; (c) Liu, J.; Dang, Q.; Wei, Z.; Zhang,
H.; Bai, X. J. Comb. Chem. 2005, 7, 627e636; (d) Nagashima, S.; Yokota,
M.; Nakai, E.-I.; Kuromitsu, S.; Ohga, K.; Takeuchi, M.; Tsukamoto, S.-I.;
Ohta, M. Biorg. Med. Chem. 2007, 15, 1044e1055; (e) Davey, D. D.;
Adler, M.; Arnaiz, D.; Eagen, K.; Erickson, S.; Guilford, W.; Kenrick,
M.; Morrissey, M. M.; Ohlmeyer, M.; Pan, G.; Paradkar, V. M.; Parkinson,
J.; Polokoff, M.; Saionz, K.; Santos, C.; Subramanyam, B.; Vergona, R.;
Wei, R. G.; Whitlow, M.; Ye, B.; Zhao, Z.; Devlin, J. J.; Phillips, G.
J. Med. Chem. 2007, 50, 1146e1157.
2.3.13. 1-(4-Methoxybenzyl)-5-chloro-3-(isobutyl-
amino)pyrazin-2(1H)-one (3e)
Yield 26%, yellow oil. 1H NMR (300 MHz, CDCl3): d 7.25
(d, J¼9.1 Hz, 2H), 6.86 (d, J¼10.1 Hz, 2H), 6.45 (s, 1H), 6.41
(br s, 1H), 4.93 (s, 2H), 3.80 (s, 3H), 3.24 (t, J¼7.0 Hz, 2H),
1.92 (m, 1H), 0.97 (d, 6H, eCHe(CH3)2). 13C NMR
(75 MHz, CDCl3): d 159.9, 150.6, 130.0, 127.3, 127.0,
114.5, 114.4, 55.4, 51.5, 48.6, 28.1, 20.4. HRMS (EI):
C17H20ClN3O2 calcd 321.1244, found 321.1241.
9. Vu, C. B.; Kiesman, W. F.; Conlon, P. R.; Lin, K.-C.; Tam, M.; Petter,
R. C.; Smits, G.; Lutterodt, F.; Jin, X.; Chen, L.; Zhang, J. J. Med.
Chem. 2006, 49, 7132e7139.
10. Dalai, S.; Below, V. N.; Nizamov, S.; Rauch, K.; Finsinger, D.; de Meijere,
A. Eur. J. Org. Chem. 2006, 12, 2753e2765.
11. (a) Kaval, N.; Bisztray, K.; Dehaen, W.; Kappe, C. O.; Van der Eycken, E.
Mol. Divers. 2003, 7, 125e134; (b) Kaval, N.; Dehaen, W.; Van der
Eycken, E. J. Comb. Chem. 2005, 7, 90e95; (c) Singh, B. K.; Appukkut-
tan, P.; Claerhout, S.; Parmar, V. S.; Van der Eycken, E. Org. Lett. 2006, 8,
1863e1866; (d) Appukkuttan, P.; Husain, M.; Gupta, R. K.; Parmar, V. S.;
Van der Eycken, E. Synlett 2006, 1491; (e) Kaval, N.; Singh, B. K.; Ermo-
Acknowledgements
Support was provided by the research fund of the Uni-
versity of Leuven and the FWO (Fund for Scientific
ResearchdFlanders (Belgium)). A.S. is thankful to the Uni-
versity of Leuven for obtaining a postdoctoral fellowship.
The authors also wish to thank Bart Demarsin for the valuable
help in HRMS data.
´
latev, D. S.; Claerhout, S.; Van der Eycken, J.; Van der Eycken, E.
J. Comb. Chem. 2007, 9, 446e453; (f) Singh, B. K.; Mehta, V. P.; Parmar,
V. S.; Van der Eycken, E. Org. Biomol. Chem. 2007, 5, 2962e2965; (g)
Ermolat’ev, D. S.; Mehta, V. P.; Van der Eycken, E. QSAR Comb. Sci.
2007, 26, 1266e1273.
12. Wan, Y.; Alterman, M.; Larhed, M.; Hallberg, A. J. Org. Chem. 2002, 67,
6232e6235.
13. The GCeLRMS experiment was performed at 160 ꢀC instead of 250 ꢀC
as routinely kept for all GCeLRMS experiments.
Supplementary data
14. Conditions: Na2CO3 (5 mmol) and DMF/H2O (1:1) (3 mL) were irradi-
ated in a sealed vial at a ceiling temperature of 140 ꢀC and a maximum
power of 150 W for 40 min (CEM DiscoverÒ). The crude mixture was
evaluated with GCeLRMS at 180 ꢀC. GCeMS analysis of pure DMF
did not show any traces of dimethylamine clearly indicating in situ gener-
ation of dimethylamine under the conditions used.
Detailed description of the spectral data (NMR, HRMS) is
included in the supplementary data. Supplementary data asso-
ciated with this article can be found in the online version, at